-
1
-
-
0035837553
-
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
-
DOI 10.1056/NEJM200105103441904
-
Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH,. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001; 344 (19): 1434-41. (Pubitemid 32402100)
-
(2001)
New England Journal of Medicine
, vol.344
, Issue.19
, pp. 1434-1441
-
-
Neer, R.M.1
Arnaud, C.D.2
Zanchetta, J.R.3
Prince, R.4
Gaich, G.A.5
Reginster, J.-Y.6
Hodsman, A.B.7
Eriksen, E.F.8
Ish-Shalom, S.9
Genant, H.K.10
Wang, O.11
Mitlak, B.H.12
Mellstrom, D.13
Oefjord, E.S.14
Marcinowska-Suchowierska, E.15
Salmi, J.16
Mulder, H.17
Halse, J.18
Sawicki, A.Z.19
-
2
-
-
0029116964
-
Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells
-
Dobnig H, Turner RT,. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology. 1995; 136 (8): 3632-8.
-
(1995)
Endocrinology
, vol.136
, Issue.8
, pp. 3632-3638
-
-
Dobnig, H.1
Turner, R.T.2
-
3
-
-
0032746174
-
Increased bone formation byprevention of osteoblast apoptosis with parathyroid hormone
-
Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC,. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest. 1999; 104 (4): 439-46. (Pubitemid 29534328)
-
(1999)
Journal of Clinical Investigation
, vol.104
, Issue.4
, pp. 439-446
-
-
Jilka, R.L.1
Weinstein, R.S.2
Bellido, T.3
Roberson, P.4
Parfitt, A.M.5
Manolagas, S.C.6
-
4
-
-
77952992328
-
Parathyroid hormone (PTH) induced bone gain is blunted in SOST overexpressing and deficient mice
-
Kramer I, Loots GG, Studer A, Keller H, Kneissel M,. Parathyroid hormone (PTH) induced bone gain is blunted in SOST overexpressing and deficient mice. J Bone Miner Res. 2010; 25 (2): 178-89.
-
(2010)
J Bone Miner Res
, vol.25
, Issue.2
, pp. 178-189
-
-
Kramer, I.1
Loots, G.G.2
Studer, A.3
Keller, H.4
Kneissel, M.5
-
5
-
-
13244267455
-
Osteoclast-derived activity in the coupling of bone formation to resorption
-
DOI 10.1016/j.molmed.2004.12.004, PII S1471491404003132
-
Martin TJ, Sims NA,. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med. 2005; 11 (2): 76-81. (Pubitemid 40193486)
-
(2005)
Trends in Molecular Medicine
, vol.11
, Issue.2
, pp. 76-81
-
-
Martin, T.J.1
Sims, N.A.2
-
6
-
-
77952961232
-
Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes
-
Gooi JH, Pompolo S, Karsdal MA, Kulkarni NH, Kalajzic I, McAhren SH, Han B, Onyia JE, Ho PW, Gillespie MT, Walsh NC, Chia LY, Quinn JM, Martin TJ, Sims NA,. Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes. Bone. 2010; 46 (6): 1486-97.
-
(2010)
Bone
, vol.46
, Issue.6
, pp. 1486-1497
-
-
Gooi, J.H.1
Pompolo, S.2
Karsdal, M.A.3
Kulkarni, N.H.4
Kalajzic, I.5
McAhren, S.H.6
Han, B.7
Onyia, J.E.8
Ho, P.W.9
Gillespie, M.T.10
Walsh, N.C.11
Chia, L.Y.12
Quinn, J.M.13
Martin, T.J.14
Sims, N.A.15
-
7
-
-
15844429135
-
The role of gp130-mediated signals in osteoclast development: Regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures
-
DOI 10.1084/jem.183.6.2581
-
Romas E, Udagawa N, Zhou H, Tamura T, Saito M, Taga T, Hilton DJ, Suda T, Ng KW, Martin TJ,. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J Exp Med. 1996; 183 (6): 2581-91. (Pubitemid 26192368)
-
(1996)
Journal of Experimental Medicine
, vol.183
, Issue.6
, pp. 2581-2591
-
-
Romas, E.1
Udagawa, N.2
Zhou, H.3
Tamura, T.4
Saito, M.5
Taga, T.6
Hilton, D.J.7
Suda, T.8
Ng, K.W.9
Martin, T.J.10
-
8
-
-
1442323644
-
Gp130-Mediated Signaling Is Necessary for Normal Osteoblastic Function in Vivo and in Vitro
-
DOI 10.1210/en.2003-0839
-
Shin HI, Divieti P, Sims NA, Kobayashi T, Miao D, Karaplis AC, Baron R, Bringhurst R, Kronenberg HM,. Gp130-mediated signaling is necessary for normal osteoblastic function in vivo and in vitro. Endocrinology. 2004; 145 (3): 1376-85. (Pubitemid 38281022)
-
(2004)
Endocrinology
, vol.145
, Issue.3
, pp. 1376-1385
-
-
Shin, H.-I.1
Divieti, P.2
Sims, N.A.3
Kobayashi, T.4
Miao, D.5
Karaplis, A.C.6
Baron, R.7
Bringhurst, R.8
Kronenberg, H.M.9
-
9
-
-
20844447535
-
Interleukin-11 receptor signaling is required for normal bone remodeling
-
DOI 10.1359/JBMR.050209
-
Sims NA, Jenkins BJ, Nakamura A, Quinn JM, Li R, Gillespie MT, Ernst M, Robb L, Martin TJ,. Interleukin-11 receptor signaling is required for normal bone remodeling. J Bone Miner Res. 2005; 20 (7): 1093-102. (Pubitemid 40863797)
-
(2005)
Journal of Bone and Mineral Research
, vol.20
, Issue.7
, pp. 1093-1102
-
-
Sims, N.A.1
Jenkins, B.J.2
Nakamura, A.3
Quinn, J.M.W.4
Li, R.5
Gillespie, M.T.6
Ernst, M.7
Robb, L.8
Martin, T.J.9
-
10
-
-
85047691524
-
Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways
-
DOI 10.1172/JCI200419872
-
Sims NA, Jenkins BJ, Quinn JM, Nakamura A, Glatt M, Gillespie MT, Ernst M, Martin TJ,. Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. J Clin Invest. 2004; 113 (3): 379-89. (Pubitemid 38544182)
-
(2004)
Journal of Clinical Investigation
, vol.113
, Issue.3
, pp. 379-389
-
-
Sims, N.A.1
Jenkins, B.J.2
Quinn, J.M.W.3
Nakamura, A.4
Glatt, M.5
Gillespie, M.T.6
Ernst, M.7
Martin, T.J.8
-
11
-
-
77950860366
-
Ciliary neurotrophic factor inhibits bone formation and plays a sex-specific role in bone growth and remodeling
-
McGregor NE, Poulton IJ, Walker EC, Pompolo S, Quinn JM, Martin TJ, Sims NA,. Ciliary neurotrophic factor inhibits bone formation and plays a sex-specific role in bone growth and remodeling. Calcif Tissue Int. 2010; 86 (3): 261-70.
-
(2010)
Calcif Tissue Int
, vol.86
, Issue.3
, pp. 261-270
-
-
McGregor, N.E.1
Poulton, I.J.2
Walker, E.C.3
Pompolo, S.4
Quinn, J.M.5
Martin, T.J.6
Sims, N.A.7
-
12
-
-
56749103188
-
Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling
-
Walker EC, McGregor NE, Poulton IJ, Pompolo S, Allan EH, Quinn JM, Gillespie MT, Martin TJ, Sims NA,. Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling. J Bone Miner Res. 2008; 23 (12): 2025-32.
-
(2008)
J Bone Miner Res
, vol.23
, Issue.12
, pp. 2025-2032
-
-
Walker, E.C.1
McGregor, N.E.2
Poulton, I.J.3
Pompolo, S.4
Allan, E.H.5
Quinn, J.M.6
Gillespie, M.T.7
Martin, T.J.8
Sims, N.A.9
-
13
-
-
76649121173
-
Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice
-
Walker EC, McGregor NE, Poulton IJ, Solano M, Pompolo S, Fernandes TJ, Constable MJ, Nicholson GC, Zhang JG, Nicola NA, Gillespie MT, Martin TJ, Sims NA,. Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice. J Clin Invest. 2010; 120 (2): 582-92.
-
(2010)
J Clin Invest
, vol.120
, Issue.2
, pp. 582-592
-
-
Walker, E.C.1
McGregor, N.E.2
Poulton, I.J.3
Solano, M.4
Pompolo, S.5
Fernandes, T.J.6
Constable, M.J.7
Nicholson, G.C.8
Zhang, J.G.9
Nicola, N.A.10
Gillespie, M.T.11
Martin, T.J.12
Sims, N.A.13
-
14
-
-
84857312108
-
Contrasting roles of leukemia inhibitory factor in murine bone development and remodeling involve region-specific changes in vascularization
-
Poulton IJ, McGregor NE, Pompolo S, Walker EC, Sims NA,. Contrasting roles of leukemia inhibitory factor in murine bone development and remodeling involve region-specific changes in vascularization. J Bone Miner Res. 2012; 27 (3): 586-95.
-
(2012)
J Bone Miner Res
, vol.27
, Issue.3
, pp. 586-595
-
-
Poulton, I.J.1
McGregor, N.E.2
Pompolo, S.3
Walker, E.C.4
Sims, N.A.5
-
15
-
-
47049124039
-
Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia
-
DOI 10.1038/nature07019, PII NATURE07019
-
Bozec A, Bakiri L, Hoebertz A, Eferl R, Schilling AF, Komnenovic V, Scheuch H, Priemel M, Stewart CL, Amling M, Wagner EF,. Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. Nature. 2008; 454 (7201): 221-5. (Pubitemid 351969891)
-
(2008)
Nature
, vol.454
, Issue.7201
, pp. 221-225
-
-
Bozec, A.1
Bakiri, L.2
Hoebertz, A.3
Eferl, R.4
Schilling, A.F.5
Komnenovic, V.6
Scheuch, H.7
Priemel, M.8
Stewart, C.L.9
Amling, M.10
Wagner, E.F.11
-
16
-
-
0027136189
-
Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6
-
DOI 10.1073/pnas.90.24.11924
-
Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, Koishihara Y, Ohsugi Y, Kumaki K, Taga T, Kishimoto T, Suda T,. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA. 1993; 90 (24): 11924-8. (Pubitemid 24008752)
-
(1993)
Proceedings of the National Academy of Sciences of the United States of America
, vol.90
, Issue.24
, pp. 11924-11928
-
-
Tamura, T.1
Udagawa, N.2
Takahashi, N.3
Miyaura, C.4
Tanaka, S.5
Yamada, Y.6
Koishihara, Y.7
Ohsugi, Y.8
Kumaki, K.9
Taga, T.10
Kishimoto, T.11
Suda, T.12
-
17
-
-
0037105542
-
IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-κB ligand, osteoprotegerin, and receptor activator of NF-κB in mouse calvariae
-
Palmqvist P, Persson E, Conaway HH, Lerner UH,. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J Immunol. 2002; 169 (6): 3353-62. (Pubitemid 35013185)
-
(2002)
Journal of Immunology
, vol.169
, Issue.6
, pp. 3353-3362
-
-
Palmqvist, P.1
Persson, E.2
Conaway, H.H.3
Lerner, U.H.4
-
18
-
-
0023928381
-
Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures
-
Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyde A, Suda T,. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology. 1988; 122 (4): 1373-82. (Pubitemid 18091966)
-
(1988)
Endocrinology
, vol.122
, Issue.4
, pp. 1373-1382
-
-
Takahashi, N.1
Yamana, H.2
Yoshiki, S.3
Roodman, G.D.4
Mundy, G.R.5
Jones, S.J.6
Boyde, A.7
Suda, T.8
-
19
-
-
33747792713
-
Parathyroid hormone controls receptor activator of NF-κB ligand gene expression via a distant transcriptional enhancer
-
DOI 10.1128/MCB.00356-06
-
Fu Q, Manolagas SC, O'Brien CA,. Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer. Mol Cell Biol. 2006; 26 (17): 6453-68. (Pubitemid 44277886)
-
(2006)
Molecular and Cellular Biology
, vol.26
, Issue.17
, pp. 6453-6468
-
-
Fu, Q.1
Manolagas, S.C.2
O'Brien, C.A.3
-
20
-
-
21844467220
-
SOST is a target gene for PTH in bone
-
DOI 10.1016/j.bone.2005.03.018, PII S8756328205001171
-
Keller H, Kneissel M,. SOST is a target gene for PTH in bone. Bone. 2005; 37 (2): 148-58. (Pubitemid 40962421)
-
(2005)
Bone
, vol.37
, Issue.2
, pp. 148-158
-
-
Keller, H.1
Kneissel, M.2
-
21
-
-
0034878897
-
Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation
-
DOI 10.1210/en.142.9.4047
-
Ma YL, Cain RL, Halladay DL, Yang X, Zeng Q, Miles RR, Chandrasekhar S, Martin TJ, Onyia JE,. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology. 2001; 142 (9): 4047-54. (Pubitemid 32802678)
-
(2001)
Endocrinology
, vol.142
, Issue.9
, pp. 4047-4054
-
-
Ma, Y.L.1
Cain, R.L.2
Halladay, D.L.3
Yang, X.4
Zeng, Q.5
Miles, R.R.6
Chandrasekhar, S.7
Martin, T.J.8
Onyia, J.E.9
-
22
-
-
26844521277
-
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: A novel mechanism for hormonal control of osteoblastogenesis
-
DOI 10.1210/en.2005-0239
-
Bellido T, Ali AA, Gubrij I, Plotkin LI, Fu Q, O'Brien CA, Manolagas SC, Jilka RL,. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology. 2005; 146 (11): 4577-83. (Pubitemid 41446595)
-
(2005)
Endocrinology
, vol.146
, Issue.11
, pp. 4577-4583
-
-
Bellido, T.1
Ali, A.A.2
Gubrij, I.3
Plotkin, L.I.4
Fu, Q.5
O'Brien, C.A.6
Manolagas, S.C.7
Jilka, R.L.8
-
23
-
-
0035282968
-
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
-
Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W,. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet. 2001; 10 (5): 537-43. (Pubitemid 32184286)
-
(2001)
Human Molecular Genetics
, vol.10
, Issue.5
, pp. 537-543
-
-
Balemans, W.1
Ebeling, M.2
Patel, N.3
Van Hul, E.4
Olson, P.5
Dioszegi, M.6
Lacza, C.7
Wuyts, W.8
Van Den Ende, J.9
Willems, P.10
Paes-Alves, A.F.11
Hill, S.12
Bueno, M.13
Ramos, F.J.14
Tacconi, P.15
Dikkers, F.G.16
Stratakis, C.17
Lindpaintner, K.18
Vickery, B.19
Foernzler, D.20
Van Hul, W.21
more..
-
24
-
-
41949089764
-
Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin
-
Robling AG, Niziolek PJ, Baldridge LA, Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido TM, Harris SE, Turner CH,. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem. 2008; 283 (9): 5866-75.
-
(2008)
J Biol Chem
, vol.283
, Issue.9
, pp. 5866-5875
-
-
Robling, A.G.1
Niziolek, P.J.2
Baldridge, L.A.3
Condon, K.W.4
Allen, M.R.5
Alam, I.6
Mantila, S.M.7
Gluhak-Heinrich, J.8
Bellido, T.M.9
Harris, S.E.10
Turner, C.H.11
-
25
-
-
78650926548
-
Gene expression patterns in bone following mechanical loading
-
Mantila Roosa SM, Liu Y, Turner CH,. Gene expression patterns in bone following mechanical loading. J Bone Miner Res. 2011; 26 (1): 100-12.
-
(2011)
J Bone Miner Res
, vol.26
, Issue.1
, pp. 100-112
-
-
Mantila Roosa, S.M.1
Liu, Y.2
Turner, C.H.3
-
26
-
-
47849098824
-
EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts
-
DOI 10.1359/jbmr.080324
-
Allan EH, Hausler KD, Wei T, Gooi JH, Quinn JM, Crimeen-Irwin B, Pompolo S, Sims NA, Gillespie MT, Onyia JE, Martin TJ,. EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts. J Bone Miner Res. 2008; 23 (8): 1170-81. (Pubitemid 352040173)
-
(2008)
Journal of Bone and Mineral Research
, vol.23
, Issue.8
, pp. 1170-1181
-
-
Allan, E.H.1
Hausler, K.D.2
Wei, T.3
Gooi, J.H.4
Quinn, J.M.W.5
Crimeen-Irwin, B.6
Pompolo, S.7
Sims, N.A.8
Gillespie, M.T.9
Onyia, J.E.10
Martin, T.J.11
-
27
-
-
0041820109
-
Differentiation potential of a mouse bone marrow stromal cell line
-
DOI 10.1002/jcb.10614
-
Allan EH, Ho PW, Umezawa A, Hata J, Makishima F, Gillespie MT, Martin TJ,. Differentiation potential of a mouse bone marrow stromal cell line. J Cell Biochem. 2003; 90 (1): 158-69. (Pubitemid 37052318)
-
(2003)
Journal of Cellular Biochemistry
, vol.90
, Issue.1
, pp. 158-169
-
-
Allan, E.H.1
Ho, P.W.M.2
Umezawa, A.3
Hata, J.-I.4
Makishima, F.5
Gillespie, M.T.6
Martin, T.J.7
-
28
-
-
0142214644
-
Targeted disruption of oncostatin M receptor results in altered hematopoiesis
-
DOI 10.1182/blood-2003-02-0367
-
Tanaka M, Hirabayashi Y, Sekiguchi T, Inoue T, Katsuki M, Miyajima A,. Targeted disruption of oncostatin M receptor results in altered hematopoiesis. Blood. 2003; 102 (9): 3154-62. (Pubitemid 37314751)
-
(2003)
Blood
, vol.102
, Issue.9
, pp. 3154-3162
-
-
Tanaka, M.1
Hirabayashi, Y.2
Sekiguchi, T.3
Inoue, T.4
Katsuki, M.5
Miyajima, A.6
-
29
-
-
33645089227
-
Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling
-
DOI 10.1152/ajpendo.00311.2005
-
Sims NA, Brennan K, Spaliviero J, Handelsman DJ, Seibel MJ,. Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling. Am J Physiol Endocrinol Metab. 2006; 290 (3): E456-62. (Pubitemid 43671691)
-
(2006)
American Journal of Physiology - Endocrinology and Metabolism
, vol.290
, Issue.3
-
-
Sims, N.A.1
Brennan, K.2
Spaliviero, J.3
Handelsman, D.J.4
Seibel, M.J.5
-
30
-
-
20844457235
-
A new staining technique for undecalcified bone sections that enhances visualization of fluorochromes
-
Horn D, Rivas P, McCluskey B, Mundy GR, Gutierrez G,. A new staining technique for undecalcified bone sections that enhances visualization of fluorochromes. J Bone Miner Res. 2002; 17: S416.
-
(2002)
J Bone Miner Res
, vol.17
-
-
Horn, D.1
Rivas, P.2
McCluskey, B.3
Mundy, G.R.4
Gutierrez, G.5
-
31
-
-
0026871349
-
Single stable reagent (Arsenazo III) for optically robust measurement of calcium in serum and plasma
-
Leary NO, Pembroke A, Duggan PF,. Single stable reagent (Arsenazo III) for optically robust measurement of calcium in serum and plasma. Clin Chem. 1992; 38 (6): 904-8.
-
(1992)
Clin Chem
, vol.38
, Issue.6
, pp. 904-908
-
-
Leary, N.O.1
Pembroke, A.2
Duggan, P.F.3
-
32
-
-
84995857103
-
Isoforms of the rat calcitonin receptor: Consequences for ligand binding and signal transduction
-
DOI 10.1210/en.135.1.183
-
Houssami S, Findlay DM, Brady CL, Myers DE, Martin TJ, Sexton PM,. Isoforms of the rat calcitonin receptor: consequences for ligand binding and signal transduction. Endocrinology. 1994; 135 (1): 183-90. (Pubitemid 24203815)
-
(1994)
Endocrinology
, vol.135
, Issue.1
, pp. 183-190
-
-
Houssami, S.1
Findlay, D.M.2
Brady, C.L.3
Myers, D.E.4
Martin, T.J.5
Sexton, P.M.6
-
33
-
-
66449117776
-
The chemokine Cxcl1 is a novel target gene of parathyroid hormone (PTH)/PTH-related protein in committed osteoblasts
-
Onan D, Allan EH, Quinn JM, Gooi JH, Pompolo S, Sims NA, Gillespie MT, Martin TJ,. The chemokine Cxcl1 is a novel target gene of parathyroid hormone (PTH)/PTH-related protein in committed osteoblasts. Endocrinology. 2009; 150 (5): 2244-53.
-
(2009)
Endocrinology
, vol.150
, Issue.5
, pp. 2244-2253
-
-
Onan, D.1
Allan, E.H.2
Quinn, J.M.3
Gooi, J.H.4
Pompolo, S.5
Sims, N.A.6
Gillespie, M.T.7
Martin, T.J.8
-
34
-
-
33947134460
-
CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment
-
DOI 10.1016/j.bone.2006.12.003, PII S8756328206009082
-
Liu F, Lee SK, Adams DJ, Gronowicz GA, Kream BE,. CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment. Bone. 2007; 40 (4): 1135-43. (Pubitemid 46394619)
-
(2007)
Bone
, vol.40
, Issue.4
, pp. 1135-1143
-
-
Liu, F.1
Lee, S.-K.2
Adams, D.J.3
Gronowicz, G.A.4
Kream, B.E.5
-
35
-
-
77953006287
-
Building bone with a SOST-PTH partnership
-
Sims NA,. Building bone with a SOST-PTH partnership. J Bone Miner Res. 2010; 25 (2): 175-7.
-
(2010)
J Bone Miner Res
, vol.25
, Issue.2
, pp. 175-177
-
-
Sims, N.A.1
-
36
-
-
0027493864
-
Regulation of cytokine expression in osteoblasts by parathyroid hormone: Rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA
-
Greenfield EM, Gornik SA, Horowitz MC, Donahue HJ, Shaw SM,. Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA. J Bone Miner Res. 1993; 8 (10): 1163-71. (Pubitemid 23308109)
-
(1993)
Journal of Bone and Mineral Research
, vol.8
, Issue.10
, pp. 1163-1171
-
-
Greenfield, E.M.1
Gornik, S.A.2
Horowitz, M.C.3
Donahue, H.J.4
Shaw, S.M.5
-
37
-
-
11144353867
-
Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor
-
DOI 10.1073/pnas.0306178101
-
Derouet D, Rousseau F, Alfonsi F, Froger J, Hermann J, Barbier F, Perret D, Diveu C, Guillet C, Preisser L, Dumont A, Barbado M, Morel A, deLapeyriere O, Gascan H, Chevalier S,. Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor. Proc Natl Acad Sci USA. 2004; 101 (14): 4827-32. (Pubitemid 38469162)
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, Issue.14
, pp. 4827-4832
-
-
Derouet, D.1
Rousseau, F.2
Alfonsi, F.3
Froger, J.4
Hermann, J.5
Barbier, F.6
Perret, D.7
Diveu, C.8
Guillet, C.9
Preisser, L.10
Dumont, A.11
Barbado, M.12
Morel, A.13
DeLapeyrieret, O.14
Gascan, H.15
Chevalier, S.16
-
38
-
-
0342735253
-
CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex
-
Elson GC, Lelievre E, Guillet C, Chevalier S, Plun-Favreau H, Froger J, Suard I, de Coignac AB, Delneste Y, Bonnefoy JY, Gauchat JF, Gascan H,. CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nat Neurosci. 2000; 3 (9): 867-72.
-
(2000)
Nat Neurosci
, vol.3
, Issue.9
, pp. 867-872
-
-
Elson, G.C.1
Lelievre, E.2
Guillet, C.3
Chevalier, S.4
Plun-Favreau, H.5
Froger, J.6
Suard, I.7
De Coignac, A.B.8
Delneste, Y.9
Bonnefoy, J.Y.10
Gauchat, J.F.11
Gascan, H.12
-
39
-
-
0028149838
-
The tripartite CNTF receptor complex: Activation and signaling involves components shared with other cytokines
-
DOI 10.1002/neu.480251111
-
Stahl N, Yancopoulos GD,. The tripartite CNTF receptor complex: activation and signaling involves components shared with other cytokines. J Neurobiol. 1994; 25 (11): 1454-66. (Pubitemid 24325068)
-
(1994)
Journal of Neurobiology
, vol.25
, Issue.11
, pp. 1454-1466
-
-
Stahl, N.1
Yancopoulos, G.D.2
-
40
-
-
0034213975
-
Receptor recognition by gp130 cytokines
-
Bravo J, Heath JK,. Receptor recognition by gp130 cytokines. EMBO J. 2000; 19 (11): 2399-411. (Pubitemid 30323530)
-
(2000)
EMBO Journal
, vol.19
, Issue.11
, pp. 2399-2411
-
-
Bravo, J.1
Heath, J.K.2
-
41
-
-
17744368457
-
The ciliary neurotrophic factor receptor α component induces the secretion of and is required for functional responses to cardiotrophin-like cytokine
-
DOI 10.1093/emboj/20.7.1692
-
Plun-Favreau H, Elson G, Chabbert M, Froger J, deLapeyriere O, Lelievre E, Guillet C, Hermann J, Gauchat JF, Gascan H, Chevalier S,. The ciliary neurotrophic factor receptor alpha component induces the secretion of and is required for functional responses to cardiotrophin-like cytokine. EMBO J. 2001; 20 (7): 1692-703. (Pubitemid 32299406)
-
(2001)
EMBO Journal
, vol.20
, Issue.7
, pp. 1692-1703
-
-
Plun-Favreau, H.1
Elson, G.2
Chabbert, M.3
Froger, J.4
Delapeyriere, O.5
Lelievre, E.6
Guillet, C.7
Hermann, J.8
Gauchat, J.-F.9
Gascan, H.10
Chevalier, S.11
-
42
-
-
0033923617
-
Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: Synergy with dexamethasone
-
DOI 10.1006/cyto.1999.0635
-
Richards CD, Langdon C, Deschamps P, Pennica D, Shaughnessy SG,. Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone. Cytokine. 2000; 12 (6): 613-21. (Pubitemid 30453489)
-
(2000)
Cytokine
, vol.12
, Issue.6
, pp. 613-621
-
-
Richards, C.D.1
Langdon, C.2
Deschamps, P.3
Pennica, D.4
Shaughnessy, S.G.5
-
43
-
-
0031010058
-
Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice
-
Ichihara M, Hara T, Kim H, Murate T, Miyajima A,. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice. Blood. 1997; 90 (1): 165-73. (Pubitemid 27276559)
-
(1997)
Blood
, vol.90
, Issue.1
, pp. 165-173
-
-
Ichihara, M.1
Hara, T.2
Kim, H.3
Murate, T.4
Miyajima, A.5
-
44
-
-
33846029473
-
Transcriptional control of receptor activator of nuclear factor-κB ligand by the protein kinase A activator forskolin and the transmembrane glycoprotein 130-activating cytokine, oncostatin M, is exerted through multiple distal enhancers
-
DOI 10.1210/me.2006-0315
-
Kim S, Yamazaki M, Shevde NK, Pike JW,. Transcriptional control of receptor activator of nuclear factor-kappaB ligand by the protein kinase A activator forskolin and the transmembrane glycoprotein 130-activating cytokine, oncostatin M, is exerted through multiple distal enhancers. Mol Endocrinol. 2007; 21 (1): 197-214. (Pubitemid 46041700)
-
(2007)
Molecular Endocrinology
, vol.21
, Issue.1
, pp. 197-214
-
-
Kim, S.1
Yamazaki, M.2
Shevde, N.K.3
Pike, J.W.4
-
45
-
-
73249152293
-
A novel distal enhancer mediates cytokine induction of mouse RANKl gene expression
-
Bishop KA, Meyer MB, Pike JW,. A novel distal enhancer mediates cytokine induction of mouse RANKl gene expression. Mol Endocrinol. 2009; 23 (12): 2095-110.
-
(2009)
Mol Endocrinol
, vol.23
, Issue.12
, pp. 2095-2110
-
-
Bishop, K.A.1
Meyer, M.B.2
Pike, J.W.3
-
46
-
-
0037073707
-
Parathyroid hormone stimulates receptor activator of NFκB ligand and inhibits osteoprotegerin expression via protein kinase a activation of cAMP-response element-binding protein
-
DOI 10.1074/jbc.M208494200
-
Fu Q, Jilka RL, Manolagas SC, O'Brien CA,. Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. J Biol Chem. 2002; 277 (50): 48868-75. (Pubitemid 35470855)
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.50
, pp. 48868-48875
-
-
Fu, Q.1
Jilka, R.L.2
Manolagas, S.C.3
O'Brien, C.A.4
-
47
-
-
70449552809
-
Critical role of activating transcription factor 4 in the anabolic actions of parathyroid hormone in bone
-
Yu S, Franceschi RT, Luo M, Fan J, Jiang D, Cao H, Kwon TG, Lai Y, Zhang J, Patrene K, Hankenson K, Roodman GD, Xiao G,. Critical role of activating transcription factor 4 in the anabolic actions of parathyroid hormone in bone. PLoS One. 2009; 4 (10): e7583.
-
(2009)
PLoS One
, vol.4
, Issue.10
-
-
Yu, S.1
Franceschi, R.T.2
Luo, M.3
Fan, J.4
Jiang, D.5
Cao, H.6
Kwon, T.G.7
Lai, Y.8
Zhang, J.9
Patrene, K.10
Hankenson, K.11
Roodman, G.D.12
Xiao, G.13
-
48
-
-
15444367508
-
Bone response to intermittent parathyroid hormone is altered in mice null for β-arrestin2
-
DOI 10.1210/en.2004-1282
-
Ferrari SL, Pierroz DD, Glatt V, Goddard DS, Bianchi EN, Lin FT, Manen D, Bouxsein ML,. Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2. Endocrinology. 2005; 146 (4): 1854-62. (Pubitemid 40396895)
-
(2005)
Endocrinology
, vol.146
, Issue.4
, pp. 1854-1862
-
-
Ferrari, S.L.1
Pierroz, D.D.2
Glatt, V.3
Goddard, D.S.4
Bianchi, E.N.5
Lin, F.T.6
Manen, D.7
Bouxsein, M.L.8
-
49
-
-
32344440164
-
Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice
-
DOI 10.1016/j.bbrc.2006.01.044, PII S0006291X06001197
-
Hurley MM, Okada Y, Xiao L, Tanaka Y, Ito M, Okimoto N, Nakamura T, Rosen CJ, Doetschman T, Coffin JD,. Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice. Biochem Biophys Res Commun. 2006; 341 (4): 989-94. (Pubitemid 43221763)
-
(2006)
Biochemical and Biophysical Research Communications
, vol.341
, Issue.4
, pp. 989-994
-
-
Hurley, M.M.1
Okada, Y.2
Xiao, L.3
Tanaka, Y.4
Ito, M.5
Okimoto, N.6
Nakamura, T.7
Rosen, C.J.8
Doetschman, T.9
Coffin, J.D.10
-
50
-
-
43749120534
-
Interleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actions
-
Raggatt LJ, Qin L, Tamasi J, Jefcoat SC Jr, Shimizu E, Selvamurugan N, Liew FY, Bevelock L, Feyen JH, Partridge NC,. Interleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actions. J Biol Chem. 2008; 283 (11): 6790-8.
-
(2008)
J Biol Chem
, vol.283
, Issue.11
, pp. 6790-6798
-
-
Raggatt, L.J.1
Qin, L.2
Tamasi, J.3
Jefcoat, Jr.S.C.4
Shimizu, E.5
Selvamurugan, N.6
Liew, F.Y.7
Bevelock, L.8
Feyen, J.H.9
Partridge, N.C.10
-
51
-
-
36048935393
-
IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone
-
DOI 10.1359/jbmr.070517
-
Wang Y, Nishida S, Boudignon BM, Burghardt A, Elalieh HZ, Hamilton MM, Majumdar S, Halloran BP, Clemens TL, Bikle DD,. IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone. J Bone Miner Res. 2007; 22 (9): 1329-37. (Pubitemid 351339678)
-
(2007)
Journal of Bone and Mineral Research
, vol.22
, Issue.9
, pp. 1329-1337
-
-
Wang, Y.1
Nishida, S.2
Boudignon, B.M.3
Burghardt, A.4
Elalieh, H.Z.5
Hamilton, M.M.6
Majumdar, S.7
Halloran, B.P.8
Clemens, T.L.9
Bikle, D.D.10
-
52
-
-
52449129231
-
Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice
-
Machado do, Reis L, Kessler CB, Adams DJ, Lorenzo J, Jorgetti V, Delany AM,. Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice. Bone. 2008; 43 (2): 264-73.
-
(2008)
Bone
, vol.43
, Issue.2
, pp. 264-273
-
-
MacHado, D.1
Reis, L.2
Kessler, C.B.3
Adams, D.J.4
Lorenzo, J.5
Jorgetti, V.6
Delany, A.M.7
-
53
-
-
77951998251
-
Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates PTH bone anabolic effects
-
Yao W, Cheng Z, Shahnazari M, Dai W, Johnson ML, Lane NE,. Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates PTH bone anabolic effects. J Bone Miner Res. 2010; 25: 190-9.
-
(2010)
J Bone Miner Res
, vol.25
, pp. 190-199
-
-
Yao, W.1
Cheng, Z.2
Shahnazari, M.3
Dai, W.4
Johnson, M.L.5
Lane, N.E.6
-
54
-
-
33845665838
-
Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1
-
DOI 10.1002/jcp.20834
-
Bodine PV, Seestaller-Wehr L, Kharode YP, Bex FJ, Komm BS,. Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1. J Cell Physiol. 2007; 210 (2): 352-7. (Pubitemid 44956880)
-
(2007)
Journal of Cellular Physiology
, vol.210
, Issue.2
, pp. 352-357
-
-
Bodine, P.V.N.1
Seestaller-Wehr, L.2
Kharode, Y.P.3
Bex, F.J.4
Komm, B.S.5
-
55
-
-
65949091145
-
Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice
-
Pierroz DD, Rufo A, Bianchi EN, Glatt V, Capulli M, Rucci N, Cavat F, Rizzoli R, Teti A, Bouxsein ML, Ferrari SL,. Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice. J Bone Miner Res. 2009; 24 (5): 775-84.
-
(2009)
J Bone Miner Res
, vol.24
, Issue.5
, pp. 775-784
-
-
Pierroz, D.D.1
Rufo, A.2
Bianchi, E.N.3
Glatt, V.4
Capulli, M.5
Rucci, N.6
Cavat, F.7
Rizzoli, R.8
Teti, A.9
Bouxsein, M.L.10
Ferrari, S.L.11
-
56
-
-
0035137316
-
Cellular distribution of constitutively active mutant parathyroid hormone (PTH)/PTH-related protein receptors and regulation of cyclic adenosine 3′,5′-monophosphate signaling by β-arrestin2
-
DOI 10.1210/me.15.1.149
-
Ferrari SL, Bisello A,. Cellular distribution of constitutively active mutant parathyroid hormone (PTH)/PTH-related protein receptors and regulation of cyclic adenosine 3′,5′-monophosphate signaling by beta-arrestin2. Mol Endocrinol. 2001; 15 (1): 149-63. (Pubitemid 32156048)
-
(2001)
Molecular Endocrinology
, vol.15
, Issue.1
, pp. 149-163
-
-
Ferrari, S.L.1
Bisello, A.2
-
57
-
-
0027741257
-
Inducibility and negative autoregulation of CREM: An alternative promoter directs the expression of ICER, an early response repressor
-
DOI 10.1016/0092-8674(93)90532-U
-
Molina CA, Foulkes NS, Lalli E, Sassone-Corsi P,. Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell. 1993; 75 (5): 875-86. (Pubitemid 24014545)
-
(1993)
Cell
, vol.75
, Issue.5
, pp. 875-886
-
-
Molina, C.A.1
Foulkes, N.S.2
Lalli, E.3
Sassone-Corsi, P.4
-
58
-
-
0031785387
-
Parathyroid hormone induces expression of the inducible cAMP early repressor in osteoblastic MC3T3-E1 cells and mouse calvariae
-
Tetradis S, Nervina JM, Nemoto K, Kream BE,. Parathyroid hormone induces expression of the inducible cAMP early repressor in osteoblastic MC3T3-E1 cells and mouse calvariae. J Bone Miner Res. 1998; 13 (12): 1846-51. (Pubitemid 28535841)
-
(1998)
Journal of Bone and Mineral Research
, vol.13
, Issue.12
, pp. 1846-1851
-
-
Tetradis, S.1
Nervina, J.M.2
Nemoto, K.3
Kream, B.E.4
|